News Novo Nordisk returns to ABPI fold after two-year suspension Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."
News EMA abandons X in favour of rival Bluesky The EMA has abandoned X for Bluesky, saying Elon Musk's social media platform "no longer suits our communication needs."
Sales & Marketing Unpacking EASD 2024: Key themes, topics, and influencers This September, Madrid played host to the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD).
Sales & Marketing Creative review: The Cannes Lions trends that pharma needs t... Pharma creative needs to stand up and be counted.
Digital DIA 2024: Charting new horizons in patient-centered R&D In its 60th year, the Drug Information Association (DIA) global annual meeting
Market Access Deepening perspectives: How social media is driving our unde... On the 31st of May, news broke that the NHS was launching its “world-first” cancer vaccine matchmaking programme.
News Industry alarm as FDA's CBER head Peter Marks resigns Industry organisations are alarmed by the resignation of senior FDA official Peter Marks, citing "misinformation and lies" by HHS Secretary Kennedy.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl